Drreddys Laboratories | RDY - 流动负债

金融业

INR

INR 6.26B

现金及等价物

INR 18.66B

INR 40.46B

INR 3.31B

INR 1.76B

INR 67.73B

股息收益率

INR 0.65

INR 16.37B

INR 21.59B

INR 27.81K

EPS每股收益

INR 0.16

股本和储备

INR 4.14B

INR 46.81B

债务利息支出

INR 944M

INR 796M

INR 129.19M

INR 2.13B

INR 12.1B

INR 72.94B

INR 14.33B

普通股股本

INR 832.57M

18.27

INR 15.43B

INR 87.27B

销售和管理费用

INR 26.92B

INR 79.01B

贸易债权人

INR 454.04M

应收帐款人

INR 1.41B

	流动负债	更改		日
ANI Pharmaceuticals	USD 278.11M		7.56M	2025-12
Aurora Cannabis	CAD 145.94M		21.82M	2025-12
Bayer	EUR 32.58B		3.63B	2025-12
Canopy Growth	CAD 98.29M		17.19M	2025-12
Cipla	INR 62.97B		8.13B	2025-09
Corcept Therapeutics	USD 166.08M		6.18M	2025-12
Drreddys Laboratories	INR 1.76B		62.5M	2025-12
GlaxoSmithKline	GBP 21.39B		57M	2025-12
Hikma Pharmaceutical	USD 1.45B		603M	2025-12
Lonza	CHF 3.57B		421M	2025-12
Novartis	USD 27.28B		4.72B	2025-12
Pacira	USD 120.59M		13.51M	2025-12
Phibro Animal Health	USD 282.37M		12.23M	2025-12
Prestige Brands	USD 139.56M		4.95M	2025-12
Richter Gedeon	HUF 171.18B		10.98B	2025-12
Sun Pharmaceuticals	INR 234.15B		52.21B	2025-09
Supernus Pharmaceuticals	USD 338.17M		7.54M	2025-12
Teva Pharmaceutical Industries	USD 13.46B		1.96B	2025-12